Latest filing published 25 May 2007 for NEOPHARM INC, €9,571.
Insider track record
No signal scores available.
Erick E. Hanson: trading record in brief
Erick E. Hanson discloses dealings in Neopharm Inc to SEC (Form 4). In total, 4 filings cover trades dated from 19 June 2006 to 24 May 2007.
Every open-market trade on record is a sale: 2 sales worth €23k. Outside the open market, there are 2 share grants. Since January 2007: no purchases and 2 sales on the market.
On 25 May 2007 came the latest disclosure, an open-market sale for €9,571 in Neopharm Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Erick E. Hanson
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 8,817 shares@ US$1.46CommonSEC:0001104659-07-043136:0
- 12,459 shares@ US$1.45CommonSEC:0001104659-07-043136:1
- 7,849 shares0CommonSEC:0001104659-06-051265:0
- 8,090 shares0CommonSEC:0001104659-06-042952:0
4 of 4 declarations